Welcome to Medicor Cancer Centres

Welcome to Medicor Cancer Centres

Welcome to Medicor Cancer Centres

Welcome to Medicor Cancer Centres

Welcome to Medicor Cancer Centres

"MOMENTUM" DCA PROTOCOL

ANOTHER MEDICOR WORLD FIRST - DEVELOPED BY DR. KHAN
Download BrochureNow Published in European Society of Medicine Journal
DCA-NAD-PDK

Colon Cancer Long-Term Survival – DCA

Case Report - Colon Cancer Long-Term Survival with DCA Therapy 57 year old female diagnosed with stage 4 rectal cancer (multiple liver metastases) partially obstructing tumour, had surgery, unable to remove main tumour so bypassed with loop ileostomy chemo (FOLFIRI +...

Breast Cancer Long-Term Survival – DCA + LDN

Case Report - Breast Cancer Long-Term Survival with DCA + LDN Therapy 60 year old female with new small superficial breast mass, refused needle biopsy excisional biopsy performed in office by Dr. Khan under local anesthesia confirmed breast cancer, ER+/PR+/HER2-,...

Throat Cancer Long-Term Survival – DCA + LDN

Case Report - Throat Cancer Long Term Survival DCA + LDN Therapy 65 year old female diagnosed with tonsillar squamous cell carcinoma in 2015 neck node metastases present at the time of diagnosis (stage 3) history of type 2 diabetes proposed radiation followed by...

Glioblastoma Long-Term Survival – DCA

Case Report - Glioblastoma Long-Term Survival with DCA Therapy 52 year old male diagnosed with a left parietal glioblastoma multiforme in 2013 treated with tumour debulking surgery and standard course of low dose chemo combined with radiation low blood cell counts due...

Glioblastoma Cure – DCA

Case Report - Glioblastoma Cured with DCA Therapy 31 year old female with grade III astrocytoma transformed to glioblastoma treated with tumour debulking surgery and standard course of low dose chemo combined with radiation patient refused monthly high dose...

Rare Tongue Cancer Cure – LDN

Case Report - Adenoid Cystic Carcinoma Cured 60 Year old male with rare adenoid cystic cancer of tongue base 3cm tumour standard therapy proposed by oncology team: radical surgery (complete removal of tongue and larynx) followed by chemo and radiation patient refused...

Powerful Non-Toxic Cancer Treatments

Integrative treatment combining traditional and natural therapies
Leading experience worldwide with metabolic therapy using oral and intravenous DCA (dichloroacetate)
Immunotherapy with oral LDN (low dose naltrexone) based on the original research of Bernard Bihari, MD, combined with high dose vitamin D
DMSO / sodium bicarbonate infusion therapy based on the research of Dr. Ba Hoang
N
anoparticle natural immune therapy cream for skin cancers or skin metastases
Full complement of well-researched intravenous supportive infusions and natural therapies (high dose vitamin C, European mistletoe, amino acids, high dose B vitamins)
Advanced oral nanoparticle / liposomal formulations of natural medicines

Medical Ozone Therapy

Natural, safe and powerful ozone therapy
B
lood ozonation (multi-pass), ozonated saline infusion, ozone insufflation, ozone tumour injection
Cancer therapy and therapy enhancement
Cancer prevention
C
hemo, radiation and surgery preconditioning, enhance post-treatment healing
Supervised by American Academy of Ozone Therapy Fellow and certified Prolozone® specialist (Dr. Khan)
Many Other Ozone Benefits

True Cancer Prevention for High Risk Individuals

Reversal of Pre-Cancer (“Carcinoma In-Situ”)

Recurrence Prevention After Completion of Cancer Therapy

Reduction of Risk of Metastases with Biopsy or Surgery

Preparation for Surgery for Optimal Outcomes

Support for Standard Chemo / Radiation – Improve Results and Reduce Side Effects

Latest Publication by Dr. Khan - Mar 2024

Mar 2024 – Another world-first publication by the Medicor team calling for a major change in the way cancer is staged! Dr. Akbar Khan and his colleagues have once again demonstrated their leadership by redefining cancer care based on the latest technologies, backed by extensive scientific evidence. Published in the prestigious European Society of Medicine Journal. PDF DOWNLOAD: A Paradigm Shift in Cancer Staging- Seeing the Unseen with Circulating Tumor Cell Measurement. JOURNAL LINK: Medical Research Archives Vol 12 No 3 (2024)

For Canadian practitioners who are unable to order Circulating Tumour Cell Counts due to jurisdiction-specific rules, your patient may order with us.

ESMED-Khan-Ghen-DCA-MOMENTUM

Grounbreaking Metabolic Cancer Publication by Dr. Khan

July 2023 – Another world-first publication by our Medical Director Dr. Akbar Khan, together with leading American physician Dr. Mitchell Ghen. Published in the European Society of Medicine special issue of Medical Research Archives: A 15 Year Evolution of Dichloroacetate-Based Metabolic Cancer Therapy: A Review with Case Reports, Medical Research Archives, [S.l.], v. 11, n. 7.2, July 2023. ISSN 2375-1924

Colon Cancer Publication by Dr. Khan

Sep 2021 – Exciting new publication by our Medical Director Dr. Akbar Khan in the new Canadian Journal of Naturopathic Medicine! Read this revealing paper about the realities of cytotoxic chemotherapy for advanced colon cancer. Get the facts before you decide if chemo is right for you.

Critical Appraisal of Approved Chemotherapy Regimens for Advanced Colon Cancer in Ontario Canada. Khan A, Can J Naturopathic Med, Vol 1, Issue 2, Sep 2021

Dr. Khan Live on CityNews

Medicor’s Medical Director and Founder Dr. Akbar Khan appeared live on CityNews to discuss former Mayor Rob Ford’s cancer diagnosis (2014).

Exciting New Immunoptherapy Film: "The Battle Within" !

This film is the culmination of decades of investigating by Dr. Ralph Moss about a profound revolution in cancer treatment, the application of one’s own immune system towards the defeat of cancer. The Battle Within refers to the battle of the immune system against cancer…and also to the battle within the medical profession over the best method of fighting cancer. Despite the enormous amount of evidence  (over 100,000 PubMed articles!) until recently, powerful financial forces have held back the field of cancer immunotherapy.

Watch the premier starting Aug 26 at 4pm EST om YouTube.

NOV 2017 METABOLIC CANCER CONFERENCE IN BALTIMORE WAS A BIG SUCCESS!

  • a new concept in cancer therapy – the metabolic approach (diet, DCA, 3BP, glutamine blocking etc)
  • over 40 speakers presented various topics
  • many renowned doctors from USA, France, Taiwan, Canada, Greece, England and Turkey (Harvard, Johns Hopkins, U of Maryland, Columbia U, Stanford, Boston College, UCSF etc.)
  • celebrity chefs and nutritionists
  • Dr. Khan presented a lecture about DCA as a non-toxic metabolic cancer therapy, and moderated a panel discussion about chemotherapy

Shocking New Article by Tom Blackwell About Cancer Drugs

“…While an early stage study found the medicine shrunk tumours in about half of patients, there is no evidence…it helps them live longer or improves their quality of life. Still, manufacturer…charged a small fortune for the drug: about $122,000 a year.”

READ NOW!

New DCA Publication!

New peer-reviewed publication from Dr. Khan and Dr. Andrews in the World Journal of Clinical Oncology!

LONG TERM STABILIZATION OF METASTATIC MELANOMA WITH DCA (PDF) (HTML)

pubmed-logoDCA therapy can result in a classic response which is measured by reduction or disappearance of tumours on imaging. However, DCA can also halt cancer cell growth without causing apoptosis (cytostatic effect). This can result in long-term stabilization of metastatic cancer. We present a case of oral DCA therapy resulting in reduction and stabilization of metastatic melanoma in a 32-year-old male for over 4 years, with only minor side effects.

World Journal of Clinical Oncology

Publications

Medicor’s medical director has published groundbreaking articles in various peer-reviewed medical journals around the world since 2011. He was the first to publish human data about dichloroacetate (DCA) in cancer symptom control, intravenous DCA as an effective cancer therapy, and the curative potential of DCA when combined with radiation. He has also published the world’s first case report on chronic use of DCA as a cancer stabilizing therapy, and a remarkable case report of cancer remission with low dose naltrexone (LDN) combined with high dose vitamin D. Read about Dr. Khan’s publications on the About our Medical Director page.

BOARD OF INTEGRATIVE MEDICINE MEMBER

Medicor’s medical director is a member of the World Organization of Natural Medicines and has been granted the titles of IMD (Integrative Medical Doctor) and DHS (Doctor of Humanitarian Service) by the Board of Integrative Medicine.

Medicor doctors have been featured regularly in the media since 2006

 

CP24-Logo680-News-LogoCHCH-TV-LogoDr-Barry-Dworkin-Logo580-CFRA-LogoEdmonton-Journal-LogoROB-TV-Logo VOL-Norway-Logo CityPulse24-Logo BT-Logo National-Post-Logo Corriere-Della-Sera-Logo
Fusion-Logo Correio-Da-Manha-Logo
Fohla-De-Sao-Paulo-Logo the-guardian-logo.jpg La-Tribune-Logo CHQR-AM-770-Logo Faith-FM-Logo MacLeans-Logo IHP-Logo CityNews-Logo